The National Institutes of Health (NIH) is forecasting a funding opportunity for the NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers, designated as a UG1 Clinical Trial Not Allowed cooperative agreement. This initiative aims to support leadership and expertise in integrating translational science into clinical trials, particularly focusing on multi-center, late-phase treatment trials across various cancer types and patient demographics. The estimated total program funding is $2 million, with an award ceiling of $850,000 and two expected awards, with the Notice of Funding Opportunity (NOFO) anticipated to be published in Fall 2024, and applications due by late February 2025. For further details, interested applicants should prepare their submissions in advance of the expected application deadline.

The National Cancer Institute (NCI) intends to issue a UG1 NCI National Clinical Trials Network (NCTN) &#65533; Network Integrated Translational Science Centers notice of funding opportunity (NOFO). The NCTN Network Group Integrated Translational Science Centers will provide support for leadership and expertise to facilitate incorporating translational science into NCTN Network Group clinical trials, including the conduct of pilot projects to collect preliminary data. The primary goal of the NCTN is the conduct of multi-center, late-phase, clinical treatment trials (i.e., randomized phase 2 and phase 3 trials) and advanced imaging trials across a broad range of cancers, modalities, and diverse patient populations as part of the NCI&apos;s overall clinical research program for adults, adolescents and young adults, and children with cancer. The NCTN also conducts, as necessary, preliminary studies needed for development of definitive trials, especially umbrella/basket trials and rare tumor trials, when an extensive, national patient catchment area is required. This Notice of Intent to Publish is being provided to allow sufficient time for applicants to develop strong applications. The NOFO is expected to be published in Fall 2024 with only one expected application due date in late February 2025. &#65533;

Notice of Intent to Publish a Funding Opportunity Announcement for NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed)

Buyer

Award Range

Eligible Applicants

Funding Category

Funding Instrument

Opportunity Category

Cost Sharing or Matching Requirement

Original Source